3.02
price down icon0.98%   -0.03
after-market Dopo l'orario di chiusura: 3.01 -0.01 -0.33%
loading

Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie

pulisher
Jul 16, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Trading Down 3.6% – Time to Sell? - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Why Cyclerion Therapeutics Inc. stock attracts strong analyst attentionVerified Return Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Cyclerion Therapeutics Inc. stock performs during market volatilityFree Stock Movement Tracking - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

FIB(fib)Low Risk Stock Strategies - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Cyclerion Therapeutics Inc. stock price move sharplySmart Return Focused Trading - Newser

Jul 15, 2025
pulisher
Jun 24, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Stock Price Down 2.4% – Here’s Why - Defense World

Jun 24, 2025
pulisher
Jun 18, 2025

Cyclerion Therapeutics Gains Shareholder Support at Annual Meeting - TipRanks

Jun 18, 2025
pulisher
May 31, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Trading 6.5% Higher – Time to Buy? - Defense World

May 31, 2025
pulisher
May 30, 2025

Regina Graul, Ph.D., Promoted to Chief Executive Officer - marketscreener.com

May 30, 2025
pulisher
May 09, 2025

Renaissance Technologies LLC Invests $34,000 in Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) - Defense World

May 09, 2025
pulisher
May 08, 2025

Cyclerion partners with Guggenheim for $20M stock sale By Investing.com - Investing.com Nigeria

May 08, 2025
pulisher
May 07, 2025

Cyclerion partners with Guggenheim for $20M stock sale - Investing.com Australia

May 07, 2025
pulisher
May 07, 2025

Cyclerion Therapeutics Enters $20M Sales Agreement - TipRanks

May 07, 2025
pulisher
May 06, 2025

CYCN: Company Stock Sale Proceeds Exclude Firm's Benefit | CYCN Stock News - GuruFocus

May 06, 2025
pulisher
Apr 21, 2025

Head to Head Survey: NewAmsterdam Pharma (NASDAQ:NAMS) vs. Cyclerion Therapeutics (NASDAQ:CYCN) - Defense World

Apr 21, 2025
pulisher
Mar 18, 2025

Dementia Market Expected to Experience Major Growth by 2032, According to DelveInsight | Charsire Biotech Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP - Barchart

Mar 18, 2025
pulisher
Mar 13, 2025

Akebia Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 13, 2025
pulisher
Feb 16, 2025

Top Gainers Today: Reborn Coffee (REBN) Leads with a 65% Surge, Cyclerion (CYCN) and Signing Day Sports (SGN) Follow – market - HPBL

Feb 16, 2025
pulisher
Feb 05, 2025

3 US Penny Stocks With Market Caps Over $10M To Consider - Simply Wall St

Feb 05, 2025
$22.01
price up icon 0.64%
$35.47
price down icon 0.37%
$104.17
price down icon 0.40%
$27.63
price down icon 2.26%
$111.04
price down icon 1.29%
biotechnology ONC
$290.35
price up icon 4.01%
Capitalizzazione:     |  Volume (24 ore):